{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T05:34:19Z","timestamp":1781588059709,"version":"3.54.5"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T00:00:00Z","timestamp":1771027200000},"content-version":"vor","delay-in-days":836,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"},{"start":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T00:00:00Z","timestamp":1695340800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2023,11,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Case Description<\/jats:title>\n                    <jats:p>We describe a case of presumptive acquired systemic lupus erythematosus secondary to phenobarbital administration in a dog, which resolved with withdrawal of the drug.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Findings<\/jats:title>\n                    <jats:p>A 3.5\u2009year-old poodle presented to a veterinary teaching hospital for Tier 1 idiopathic epilepsy and was treated with phenobarbital. The dog experienced fever, multiple cytopenias, and proteinuria in conjunction with a positive antinuclear antibody (ANA) titer.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Diagnostics<\/jats:title>\n                    <jats:p>Serial CBCs, urine protein\u2009:\u2009creatinine ratios, and sternal bone marrow aspirates were performed to evaluate improvement.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Treatment and Outcome<\/jats:title>\n                    <jats:p>Phenobarbital was withdrawn and levetiracetam initiated. All abnormalities resolved with supportive care, without initiation of immunosuppressive drugs. All cytopenias and proteinuria resolved and ANA test results became negative within 3\u2009months. The patient recovered and did well clinically.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Clinical Relevance<\/jats:title>\n                    <jats:p>Systemic lupus erythematosus is a disease of multiple autoimmune syndromes occurring concurrently or sequentially in conjunction with the presence of circulating ANA. It has been well described in dogs as an idiopathic condition, but in human medicine may occur secondary to drug reactions (drug-associated lupus) including as a reaction to phenobarbital. The findings in our case are consistent with the criteria for drug-induced lupus in humans and we suggest it as the first report of phenobarbital-induced lupus in a dog.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/jvim.16882","type":"journal-article","created":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T06:11:41Z","timestamp":1695363101000},"page":"2482-2487","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Presumptive phenobarbital-induced systemic lupus erythematosus in a domestic dog"],"prefix":"10.1093","volume":"37","author":[{"given":"Erin","family":"Phillips","sequence":"first","affiliation":[{"name":"Ontario Veterinary College, University of Guelph Department of Clinical Studies, , Guelph, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5928-9262","authenticated-orcid":false,"given":"Matthew","family":"Kornya","sequence":"additional","affiliation":[{"name":"Ontario Veterinary College, University of Guelph Department of Clinical Studies, , Guelph, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Collier","sequence":"additional","affiliation":[{"name":"Ontario Veterinary College, University of Guelph Department of Clinical Studies, , Guelph, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Barry","sequence":"additional","affiliation":[{"name":"Ontario Veterinary College, University of Guelph Department of Clinical Studies, , Guelph, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Morrison","sequence":"additional","affiliation":[{"name":"Ontario Veterinary College, University of Guelph Department of Pathobiology, , Guelph, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe","family":"Reggeti","sequence":"additional","affiliation":[{"name":"Animal Health Laboratories, Laboratory Services Division, University of Guelph , Guelph, Ontario,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,11,1]]},"reference":[{"issue":"6","key":"2026021401272642200_jvim16882-bib-0001","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1002\/art.40930","article-title":"2019 European League Against Rheumatism\/American College of Rheumatology Classification Criteria for systemic lupus erythematosus","volume":"71","author":"Aringer","year":"2019","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0002","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/096120339200100303","article-title":"Canine systemic lupus erythematosus. I: A study of 75 cases","volume":"1","author":"Fournel","year":"1992","journal-title":"Lupus"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0003","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/S0021-9975(08)80286-1","article-title":"Canine systemic lupus erythematosus: new insights and their implications","volume":"108","author":"Jones","year":"1993","journal-title":"J Comp Pathol"},{"key":"2026021401272642200_jvim16882-bib-0004","article-title":"Drug-induced Lupus Erythematosus","author":"Solhjoo","year":"2022"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0005","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/vco.12517","article-title":"Outcome and failure patterns of localized sinonasal lymphoma in cats treated with first-line single-modality radiation therapy: a retrospective study","volume":"17","author":"Meier","year":"2019","journal-title":"Vet Comp Oncol"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0006","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1542\/peds.57.4.529","article-title":"Antinuclear antibodies and lupus-like syndromes in children receiving anticonvulsants","volume":"57","author":"Singsen","year":"1976","journal-title":"Pediatrics"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0007","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/S0022-3476(73)80027-7","article-title":"Anticonvulsant-induced antinuclear antibodies and lupus-like disease in children","volume":"82","author":"Beernink","year":"1973","journal-title":"J Pediatr"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0008","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1111\/j.1528-1167.2009.02144.x","article-title":"Ethosuximide-induced de novo systemic lupus erythematosus with anti-double-strand DNA antibodies: a case report with definite evidence","volume":"50","author":"Crespel","year":"2009","journal-title":"Epilepsia"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0009","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1084\/jem.134.2.417","article-title":"Canine systemic lupus erythematosus. Genetic analysis of an established breeding colony","volume":"134","author":"Lewis","year":"1971","journal-title":"J Exp Med"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0010","first-page":"1","article-title":"Cutaneous lupus erythematosus in dogs: a comprehensive review","volume":"14","author":"Olivry","year":"2018","journal-title":"BMC Vet Res"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0011","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/0041-008X(81)90242-8","article-title":"Hydralazine-induced antinuclear antibodies in beagle dogs","volume":"57","author":"Balazs","year":"1981","journal-title":"Toxicol Appl Pharmacol"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0012","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1002\/art.1780310517","article-title":"Dose-dependent induction of anti-native DNA antibodies in cats by propylthiouracil","volume":"31","author":"Aucoin","year":"1988","journal-title":"Arthritis Rheum"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0013","first-page":"1","article-title":"Antiepileptic drugs' tolerability and safety\u2014a systematic review and meta-analysis of adverse effects in dogs","volume":"12","author":"Charalambous","year":"2016","journal-title":"BMC Vet Res"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0014","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/s12917-015-0465-y","article-title":"International veterinary epilepsy task force consensus proposal: outcome of therapeutic interventions in canine and feline epilepsy","volume":"11","author":"Potschka","year":"2015","journal-title":"BMC Vet Res"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0015","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/vcp.12036","article-title":"Comparison of sternal, iliac, and humeral bone marrow aspiration in beagle dogs","volume":"42","author":"Defarges","year":"2013","journal-title":"Vet Clin Pathol"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0016","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1748-5827.2008.00564.x","article-title":"Transient leucopenia, thrombocytopenia and anaemia associated with severe acute phenobarbital intoxication in a dog","volume":"49","author":"Khoutorsky","year":"2008","journal-title":"J Small Anim Pract"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0017","first-page":"1341","article-title":"Pancytopenia secondary to suspected idiosyncratic phenobarbital reaction in a dog","volume":"62","author":"Oberholster","year":"2021","journal-title":"Can Vet J"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0018","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/vcp.13013","article-title":"Bone marrow, blood, and clinical findings in dogs treated with phenobarbital","volume":"50","author":"Scott","year":"2021","journal-title":"Vet Clin Pathol"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0019","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.2460\/ajvr.1984.45.07.1283","article-title":"Pharmacokinetics of phenobarbital in dogs after multiple oral administration","volume":"45","author":"Ravis","year":"1984","journal-title":"Am J Vet Res"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/vcp.12227","article-title":"Alkaline phosphatase is a useful cytochemical marker for the diagnosis of acute myelomonocytic and monocytic leukemia in the dog","volume":"44","author":"Stokol","year":"2015","journal-title":"Vet Clin Pathol"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0021","first-page":"1665","article-title":"Anticonvulsant hypersensitivity syndrome: incidence, prevention and management","volume":"21","author":"Papp","year":"1999","journal-title":"Drug Saf"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0022","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s10072-014-1701-0","article-title":"Anticonvulsant drugs and hematological disease","volume":"35","author":"Verrotti","year":"2014","journal-title":"Neurol Sci"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0023","doi-asserted-by":"crossref","first-page":"5359","DOI":"10.4049\/jimmunol.168.10.5359","article-title":"Characterization of drug-specific T cells in phenobarbital-induced eruption","volume":"168","author":"Hashizume","year":"2002","journal-title":"J Immunol"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0024","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1172\/JCI113798","article-title":"Anticonvulsant hypersensitivity syndrome. In vitro assessment of risk","volume":"82","author":"Shear","year":"1988","journal-title":"J Clin Invest"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0025","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1592\/phco.27.10.1425","article-title":"Anticonvulsant hypersensitivity syndrome: implications for pharmaceutical care","volume":"27","author":"Bohan","year":"2007","journal-title":"Pharmacotherapy"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0026","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1111\/bjd.15423","article-title":"Recent advances in the understanding of severe cutaneous adverse reactions","volume":"177","author":"Adler","year":"2017","journal-title":"Br J Dermatol"},{"key":"2026021401272642200_jvim16882-bib-0027","article-title":"Drug-induced Lupus Erythematosus","author":"Solhjoo","year":"2022"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0028","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s11926-011-0227-1","article-title":"Drug-induced lupus anticoagulants and antiphospholipid antibodies","volume":"14","author":"Dlott","year":"2012","journal-title":"Curr Rheumatol Rep"},{"issue":"6","key":"2026021401272642200_jvim16882-bib-0029","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3390\/pediatric14020026","article-title":"Drug-induced lupus secondary to ethosuximide in association with acute tubulointerstitial nephritis and nephrotic syndrome","volume":"14","author":"Aly","year":"2022","journal-title":"Pediatr Rep"}],"container-title":["Journal of Veterinary Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/37\/6\/2482\/66895522\/jvim16882.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jvim\/article-pdf\/37\/6\/2482\/66895522\/jvim16882.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T06:27:37Z","timestamp":1771050457000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jvim\/article\/37\/6\/2482\/8483267"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,1]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,11,1]]}},"URL":"https:\/\/doi.org\/10.1111\/jvim.16882","relation":{},"ISSN":["1939-1676"],"issn-type":[{"value":"1939-1676","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,11]]},"published":{"date-parts":[[2023,11,1]]},"assertion":[{"value":"2023-03-16","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-11","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-09-22","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}